FDA Investigator Connie P Rezendes

Connie P Rezendes has inspections in 1 countries as of 14 Jul 2023. Connie P Rezendes has collaborated with a combinined 2474 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
98
Last Inspection Date:
14 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
100005750
Country:
United States of America
Co-Investigator(s):
Abby M Miller, Alan P Kurtzberg, Alexander M Kay, Alicia A Borg Borm, Andrew R Wasko, Anita Narula, PhD, Anthony R Petriella, Ashar P Parikh, Astrida B Mattson, Atrida B Mattson, Barbar J Breithaupt, Barbara Janine Breithaupt, Bradley Dworak, PhD, Brenda K Alford, Carl A Anderson, Caryn M Mcnab, Charles R Bonapace, PhD, Christian D Lynch (CDL), Christine A Harman, PhD, Christopher R Czajka, Conmie P Rezendes, Connie P Rezenes, Connie Rezendes, Ct Viswanathan, PhD, Cynthia J Lee, MS, Cynthia L Gorveatt, Da Lin Yao, MD, PhD, Dandan Wang, PhD, David J Daworski, Dawn E Barkans, Dennis R Hudson, Diane T Wade, MS, Dianne B Latona, Dolores E Price, Don H Bark, PhD, Donald B Mckechnie, Donald W Jehn, Dov H Pluznik, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Harris, Edwin Melendez, Eileen A Liu, Elizabeth S Howell, Eric L Dong, BS, Eric L Scott, Erin M Mcdowell, Farhana Khan, Gerard Pde Leon, Gina C Collins, Gloria J Baca, MS, Gordon T Wales, Grace P Santos, Heika R Bounds, Heika R Tait, Hugh M Mcclure, II, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, James C Henry, James I Vik, James S Cartwright, Jane M Krais, Jane M Kreis, Jeanne M Weishaar, Jennifer L Bridgewater, Joey V Quitania, John A Gonzalez, John W Banks, Joshua P Wireman, Julian C Hanson, June H Wetherington, Kari M Johansen, Katharine Chan, Kathryn A Krentz, Kelsey M Bishop, Kenneth O Gee, PhD, Kimberly J Proctor Jones, Kristin M Abaonza, Lance W Bohm, Laurel A Beer, Lauren E Swantko, Lawrence Y Lee, PhD, LCDR Debra Emerson, Lesley A Swanson, Liming Zhang, Linda F Murphy, Linda S Leja, Lisa A Bowden, Lisa K Capron, Lori J Silverstein, Lynda L Perry, PhD, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark W Babbitt, Maxine H Wong, Michael F Skelly, PhD, Mihaly S Ligmond, Mikel T Wright, Nancy A Saxenian Emmons, Nancy E Byerly, Omotunde O Osunsanmi, Paul M Kawamoto, Paula A Trost, Peter C Chow, Prabhu P Raju, Randy L Self, Rebecca Rodriguez, Rebecca T Davis, Richard G Runyon, Robert D Tollefsen, Roger F Zabinski, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Savini, Scott N Lim, Sharon I Gundersen, Sherri N Rohlf, MD, State Agency, Stephen R Souza, Sunitha K Rajaram, PhD, Susan F Laska, MS, Terri L Dodds, Terry L Dodds, Thomas C Mclean, CFS, Thomas J Arista, Tina S Roecklein, Tracy K Li, Uttaniti Limchumroon (Tom), V Teres Speer, Vitaliy N Guyvan, William A Burkey, William C Hughes, Xiomara Copeland

Connie P Rezendes's Documents

Publish Date Document Type Title
February, 2000 FDA 483 Patrick Simning, M.D. - Form 483, 2000-02-11
February, 2004 FDA 483 Contract Supplement Packaging - Form 483, 2004-02-27
August, 2003 EIR Rich Nature Nutraceutical Laboratories, Inc. - EIR, 2003-08-07
December, 2005 FDA 483 Northwest Cosmetic Laboratories L.L.C. DBA Elevation Labs, Idaho - Form 483, 2005-12-15
May, 2001 FDA 483 Response Brian J. Druker, MD - Form 483R, 2001-05-13
October, 2001 EIR Airgas USA, LLC - EIR, 2001-10-16
July, 2002 EIR Crisor, LLC - EIR, 2002-07-03
May, 2001 FDA 483 Brian J. Druker, MD - Form 483, 2001-05-09
November, 2003 EIR Evergreen Pharmaceutical, Inc. - EIR, 2003-11-05
October, 2002 EIR Saul H. Helfing, MD - EIR, 2002-10-17
August, 2003 EIR St. Charles Medical Center - EIR, 2003-08-14
May, 2004 EIR Crisor, LLC - EIR, 2004-05-06
July, 2002 FDA 483 Crisor, LLC - Form 483, 2002-07-03
January, 2003 EIR Jubilant HollisterStier LLC - EIR, 2003-01-24
November, 2003 FDA 483 Evergreen Pharmaceutical, Inc. - Form 483, 2003-11-05
May, 2001 EIR Brian J. Druker, MD - EIR, 2001-05-09
July, 2000 EIR Immunex Corp. - EIR, 2000-07-28
February, 2000 EIR Patrick Simning, M.D. - EIR, 2000-02-11
June, 2001 EIR Dana C. Matthews, MD/PI - EIR, 2001-06-15
April, 2002 FDA 483 Reddish Pharmacy, Inc. - Form 483, 2002-04-08
April, 2003 FDA 483 Jubilant HollisterStier LLC - Form 483, 2003-04-11
March, 2001 FDA 483 Norco, Inc DBA Norco Medical - Form 483, 2001-03-15
January, 2003 FDA 483 Jubilant HollisterStier LLC - Form 483, 2003-01-24
March, 2005 FDA 483 Melaleuca - Form 483, 2005-03-25
January, 2003 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2003-01-28
June, 2001 FDA 483 Dana C. Matthews, MD/PI - Form 483, 2001-06-15
September, 2000 FDA 483 Rich Distributing - Form 483, 2000-09-29
October, 2003 EIR Immunex Corp. - EIR, 2003-10-31
April, 2003 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2003-04-22
April, 2003 EIR Jubilant HollisterStier LLC - EIR, 2003-04-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more